Literature DB >> 30738608

Quantification of doxorubicin-induced interstitial myocardial fibrosis in a beagle model using equilibrium contrast-enhanced computed tomography: A comparative study with cardiac magnetic resonance T1-mapping.

Zhen Zhou1, Lei Xu2, Rui Wang1, Akos Varga-Szemes3, James A Durden3, U Joseph Schoepf3, Zhonghua Sun4, Zhanming Fan1.   

Abstract

BACKGROUND: The noninvasive equilibrium contrast-enhanced cardiac computed tomography (CCT) has potential for myocardial tissue characterization. The objective of this study was to test the feasibility of CCT-based extracellular volume (ECV) fraction in beagle models of doxorubicin-induced interstitial myocardial fibrosis, with cardiac magnetic resonance (CMR) as the reference.
METHODS: This study was approved by local ethics committee. Thirteen beagles were included with ECV quantified by CCT and CMR at baseline, 16 and 24 weeks after modeling. Spearman correlation analysis was used to determine the association between CT ECV, CMR ECV, collagen volume fraction (CVF), LVEF and serum fibrosis index (Hyaluronic acid [HA], Laminin [LN] and Type-III procollagen [PCIII]).
RESULTS: Median ECV values in CT and CMR at 16 and 24 weeks were significantly higher than those at baseline (CT ECV: 34.4% and 37.7% vs. 25.2%; CMR ECV: 32.2% and 37.4% vs. 22.7%; P < 0.001). A strong correlation was found between CCT and CMR for ECV (r = 0.899, P < 0.001). Both correlated well with CVF (r = 0.951 and 0.879 for CT and MR ECV vs. CVF, P < 0.001), serum fibrosis index (r = 0.830-0.907 for CT and MR ECV vs. HA, LN, PCIII, respectively, P < 0.05) and were inversely related to LVEF (r = -0.846 and -0.804 for CCT and CMR, P < 0.001). Bland-Altman analysis showed a small bias (1.5%), with 95% limits of agreement of -2.7% and 5.6%.
CONCLUSIONS: CCT-derived ECV correlates well with CMR, histology and serum fibrosis index, suggesting that CCT is capable of myocardial tissue characterization.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac magnetic resonance imaging; Diffuse interstitial myocardial fibrosis; Equilibrium contrast-enhanced computed tomography; Extracellular volume fraction; Serum fibrosis index

Mesh:

Substances:

Year:  2019        PMID: 30738608     DOI: 10.1016/j.ijcard.2019.01.021

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Detection of Myocardial Fibrosis and Left Ventricular Dysfunction with Cardiac MRI in a Hypertensive Swine Model.

Authors:  Baiyan Zhuang; Chen Cui; Arlene Sirajuddin; Jian He; Xin Wang; Guangxin Yue; Xuejing Duan; Hongyue Wang; Andrew E Arai; Shihua Zhao; Minjie Lu
Journal:  Radiol Cardiothorac Imaging       Date:  2020-08-27

2.  Analysis of alterations of serum inflammatory cytokines and fibrosis makers in patients with essential hypertension and left ventricular hypertrophy and the risk factors.

Authors:  Xia Li; Xiaofan Guo; Ye Chang; Naijin Zhang; Yingxian Sun
Journal:  Am J Transl Res       Date:  2022-06-15       Impact factor: 3.940

Review 3.  Cardiac Remodelling Following Cancer Therapy: A Review.

Authors:  Tan Panpan; Du Yuchen; Shi Xianyong; Liu Meng; He Ruijuan; Dong Ranran; Zhang Pengyan; Li Mingxi; Xie Rongrong
Journal:  Cardiovasc Toxicol       Date:  2022-07-25       Impact factor: 2.755

Review 4.  Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity.

Authors:  Attila Feher; Lauren A Baldassarre; Albert J Sinusas
Journal:  Front Cardiovasc Med       Date:  2022-04-27

5.  Myocardial extracellular volume fraction analysis in doxorubicin-induced beagle models: comparison of dual-energy CT with equilibrium contrast-enhanced single-energy CT.

Authors:  Zhen Zhou; Yifeng Gao; Hongwei Wang; Wenjing Wang; Hongkai Zhang; Sicong Wang; Zhonghua Sun; Lei Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-02

6.  Cardiac extracellular volume fraction in cats with preclinical hypertrophic cardiomyopathy.

Authors:  Ryan C Fries; Saki Kadotani; Stephanie C J Keating; Jonathan P Stack
Journal:  J Vet Intern Med       Date:  2021-02-26       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.